Basic Information
Basic information for LINC01503-215-13aa
Peptide Name LINC01503-215-13aa
Genome Position chr9:129341987-129342025[+]
Species Human
Peptide Sequence MRWVVSLGTNAEP
Peptide Length 13
Unique No (LINC01503-201-13aa,LINC01503-202-13aa-2,LINC01503-203-13aa,LINC01503-204-13aa,LINC01503-205-13aa,LINC01503-206-13aa,LINC01503-207-13aa,LINC01503-208-13aa,LINC01503-209-13aa,LINC01503-210-13aa,LINC01503-211-13aa,LINC01503-212-13aa,LINC01503-213-13aa,LINC01503-214-13aa-1)
Grand Average of Hydropathicity 0
Relative Molecular Mass 1675.89
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000233901;LINC01503
Transcript ID/Name ENST00000665063;LINC01503-215
Transcript Length 2226
Coding Ability 0.2421
DNA Sequence Corresponding to Peptide ATGCGCTGGGTGGTGAGCCTGGGGACGAATGCAGAGCCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :